Alzheimer Treatment (Biochemistry)

Alzheimer's disease has been identified as a protein misfolding disease (Proteopathy) abnormally folded proteins and beta-definition of accumulation in the brain and Tau. Length of small peptides, amino acids, called amyloid beta, 39 and 43 of disks (also written, and beta or Aβ). Amyloid beta precursor protein transmembrane protein, called amyloid (APP), which is a neural membrane split, such as enter. Implementation is crucial to the growth of nerve cells, survival and compensation mail. "Alzheimer's disease, has been hampered by an unknown process into many small APP to filing of enzymes". "One of these amyloid-beta protein fibres in the fragments, dense deposits outside neurons known as senile plaques these configurations.

Advertising, also considered to be abnormal Tau protein aggregation, caused by a Tauopathy. Each neuron in the cytoskeleton, is part of the mikrotubulami structure is called the internal supporting structure. Mikrotubulami of this law, for example, the numbers of molecules of nutrients, cell body and Axon terminates at the rear. The temperature of the protein Tau, phosphorylated proteins, has stabilised insulated when associated with mikrotubulami and mikrotubulami. The hyperphosphorylated Tau are chemical changes, problems, and other threads, the cells of the nervous system deterioration in the transport system.